These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16291374)

  • 21. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
    Medeot M; Zaja F; Vianelli N; Battista M; Baccarani M; Patriarca F; Soldano F; Isola M; De Luca S; Fanin R
    Eur J Haematol; 2008 Sep; 81(3):165-9. PubMed ID: 18510702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombocytopenic idiopathic purpura: predictive factors for chronic disease].
    Mazigh Mrad S; Ouedemi M; Bouyahia O; Gharsallah L; Boukthir S; Gharbi AS
    Tunis Med; 2009 Jan; 87(1):72-5. PubMed ID: 19522431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children.
    Glanz J; France E; Xu S; Hayes T; Hambidge S
    Pediatrics; 2008 Mar; 121(3):e506-12. PubMed ID: 18310170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of idiopathic thrombocytopenic purpura in children: the experience of 92 cases].
    Wang YC; Hu LQ; Zhang JS
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):486-8. PubMed ID: 17937865
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors predicting development of chronic disease in Nordic children with acute onset of idiopathic thrombocytopenic purpura.
    Rosthøj S; Hedlund-Treutiger I; Rajantie J; Zeller B;
    Br J Haematol; 2005 Jul; 130(1):148-9; author reply 150. PubMed ID: 15982360
    [No Abstract]   [Full Text] [Related]  

  • 26. Rituximab for the treatment of childhood chronic idiopathic thrombocytopenic purpura and hemophilia with inhibitors.
    Franchini M; Zaffanello M; Veneri D; Lippi G
    Pediatr Blood Cancer; 2007 Jul; 49(1):6-10. PubMed ID: 17311349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura.
    Benedetti L; Franciotta D; Beronio A; Cadenotti L; Gobbi M; Mancardi GL; Schenone A; Tartaglione A
    Muscle Nerve; 2008 Aug; 38(2):1076-7. PubMed ID: 18642360
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease.
    Treliński J; Chojnowski K; Kurenko-Deptuch M; Kasznicki M; Bernatowska E; Robak T
    Ann Hematol; 2005 Nov; 84(12):835-6. PubMed ID: 16078034
    [No Abstract]   [Full Text] [Related]  

  • 29. Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP).
    Alasfoor K; Alrasheed M; Alsayegh F; Mousa SA
    Ann Hematol; 2009 Mar; 88(3):239-43. PubMed ID: 18704420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab use in pediatric autoimmune diseases: four case reports.
    Polido-Pereira J; Ferreira D; Rodrigues AM; Nascimento C; Costa P; Almeida M; da Silva JE; Simão C; Stone R; Ramos F; Neto A; da Costa JC; Melo-Gomes J; Gomes-Pedro J; Viana-Queiroz M; Canhão H; Fonseca JE
    Ann N Y Acad Sci; 2009 Sep; 1173():712-20. PubMed ID: 19758220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Childhood autoimmune cytopenia secondary to unsuspected common variable immunodeficiency.
    Heeney MM; Zimmerman SA; Ware RE
    J Pediatr; 2003 Nov; 143(5):662-5. PubMed ID: 14615742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of cyclosporine as a single agent therapy in chronic idiopathic thrombocytopenic purpura.
    Choudhary DR; Naithani R; Mahapatra M; Kumar R; Mishra P; Saxena R
    Haematologica; 2008 Oct; 93(10):e61-2; discussion e63. PubMed ID: 18827257
    [No Abstract]   [Full Text] [Related]  

  • 34. Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP).
    Swords R; Power D; Fay M; O'Donnell R; Murphy PT
    Am J Hematol; 2004 Sep; 77(1):103-4. PubMed ID: 15307117
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of megadose methylprednisolone therapy on the immune system in childhood immune thrombocytopenia.
    Yetgin S; Yenicesu IC; Ersoy F
    Pediatr Hematol Oncol; 2005; 22(5):401-7. PubMed ID: 16020130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
    Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR;
    Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency.
    Mahévas M; Le Page L; Salle V; Cevallos R; Smail A; Duhaut P; Ducroix JP
    Am J Hematol; 2006 Aug; 81(8):645-6. PubMed ID: 16823831
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura.
    Ojeda-Uribe M; Federici L; Wolf M; Coppo P; Veyradier A
    Transfusion; 2010 Mar; 50(3):733-5. PubMed ID: 20609201
    [No Abstract]   [Full Text] [Related]  

  • 39. Splenectomy in children with chronic ITP: long-term efficacy and relation between its outcome and responses to previous treatments.
    Ramenghi U; Amendola G; Farinasso L; Giordano P; Loffredo G; Nobili B; Perrotta S; Russo G; Zecca M
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):742-5. PubMed ID: 16933239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
    Santos ES; Arosemena LR; Raez LE; O'Brien C; Regev A
    Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.